SCHEMBL1017308

SCHEMBL1017308

CC1CCCC2CN(C(=O)CN3CCc4nc(-c5cncnc5)ccc4C3)CCN12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 2/20 0.34
CHRM4 P08173 2/20 0.34
CHRM1 P11229 2/20 0.34
HRH3 Q9Y5N1 3/20 0.34
CHRM3 P20309 1/20 0.34
KCNH2 Q12809 1/20 0.34
CDK4 P11802 6/20 0.33
CDK2 P24941 5/20 0.33
CDK6 Q00534 5/20 0.33
ITK Q08881 1/20 0.33
CDK1 P06493 3/20 0.32
CDK7 P50613 2/20 0.32
CDK9 P50750 2/20 0.32
ALDH1A1 P00352 3/20 0.32
SMN1; SMN2 Q16637 2/20 0.31
GAA P10253 1/20 0.31
S1PR1 P21453 1/20 0.31
ADAMTS5 Q9UNA0 1/20 0.31
MAPK1 P28482 3/20 0.31
CCNB1 P14635 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12707147 1.00 CHRM2 (0.34) CHRM2CHRM4CHRM1HRH3CHRM3
SCHEMBL12707155 0.87 ALDH1A1 (0.39) ITKALDH1A1GAAMAPK1LMNA
SCHEMBL1013680 0.87 ALDH1A1 (0.39) ITKALDH1A1GAAMAPK1LMNA
SCHEMBL1018691 0.85 HRH3 (0.43) HRH3KCNH2CDK4CDK2CDK6
SCHEMBL1013903 0.85 HRH3 (0.38) CHRM2CHRM4CHRM1HRH3CHRM3
SCHEMBL12707069 0.85 HRH3 (0.38) CHRM2CHRM4CHRM1HRH3CHRM3
SCHEMBL12707139 0.84 ALDH1A1 (0.34) CHRM2CHRM4CHRM1HRH3CHRM3
SCHEMBL1017466 0.84 ALDH1A1 (0.34) CHRM2CHRM4CHRM1HRH3CHRM3
SCHEMBL1018300 0.82 RAB9A (0.39) HRH3ITKALDH1A1SMN1; SMN2GAA
SCHEMBL12707075 0.82 RAB9A (0.39) HRH3ITKALDH1A1SMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110082130-A1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES LIGAND PHARMACEUTICALS, INC. (US) 2011-04-07 US disclosed
EP-1998620-B1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES NEUROGEN CORP (US) 2011-01-12 EP disclosed
US-7795262-B2 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION (US) 2010-09-14 US disclosed
US-20070232591-A1 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION 2007-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232591-A1 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues HRH3, HRH4, HRH1 CHRM2 83/4885CHRM4 231/4885CHRM1 139/4885
US-20110082130-A1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES HRH3, HRH4, HRH1 CHRM2 83/4885CHRM4 231/4885CHRM1 139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.